🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS...
Status
Recruiting
Location
Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites autoimmunes
Start Date
2022-02-01
Trial ID
NCT05772611
Treatments Being Tested
Hyponatremia is a frequent complication of subarachnoid hemorrhage (SAH) wi...
Status
Unknown
Location
Hopital Femme Mère Enfant
Start Date
2022-10-01
Trial ID
NCT05942755
Modulation of beta-amyloid levels in CSF and plasma by GSK933776 in patient...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-19
Trial ID
NCT01424436
Single center, non-randomized, Phase 0 study. Sacituzumab Govitecan given p...
Status
Completed
Location
Mays Cancer Center, UT Health San Antonio
Start Date
2019-07-17
Trial ID
NCT03995706
Treatments Being Tested
The Swedish BioFINDER 2 study is a new study that will launch in 2017 and e...
Status
Recruiting
Location
Memory Clinic, Hospital of Ängelholm
Start Date
2017-05-15
Trial ID
NCT03174938
Alzheimer's disease (AD) has a presymptomatic course which can last from se...
Status
Unknown
Location
AOU Careggi
Start Date
2020-10-01
Trial ID
NCT05569083
Despite its use for decades all over the world, the exact mechanism of acti...
Status
Completed
Location
St Bartholomew's Hospital
Start Date
2011-05
Trial ID
NCT01821872
Treatments Being Tested
The most clinically meaningful way to discover new targets of T cells in au...
Status
Recruiting
Location
Knowledge Research Center
Start Date
2023-01-03
Trial ID
NCT06587828
Treatments Being Tested
Using a retrospective cohort of 501 patients with anti-NMDAR encephalitis t...
Status
Unknown
Location
Hôpital Neurologique Pierre Wertheimer / Groupement Hospitalier Est
Start Date
2022-02-01
Trial ID
NCT05738668
Treatments Being Tested
Progranulin (GRN or PGRN) mutations are among the most common genetic cause...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01
Trial ID
NCT06711510